Showing results (1851-1860 of 3,794) with videos related to

Sort By:
Pageof 380
Oncoimmunology|October 10, 2015
Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencingMiran Jang, Poh-Yin Yew, Kosei Hasegawa, et al.
Oncoimmunology|October 10, 2015
Natural killer cell mediated immunosurveillance of pediatric neuroblastomaMichaela Semeraro, Sylvie Rusakiewicz, Laurence Zitvogel, et al.
Oncoimmunology|October 10, 2015
In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activityMichaela Prchal-Murphy, Agnieszka Witalisz-Siepracka, Karoline T Bednarik, et al.
Oncoimmunology|October 10, 2015
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myelomaBarbara Castella, Myriam Foglietta, Patrizia Sciancalepore, et al.
Oncoimmunology|October 10, 2015
Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomasBrian Ahn, Gary Kohanbash, Takayuki Ohkuri, et al.
Oncoimmunology|May 4, 2016
Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimeticSiddik Sarkar, Anjan Pradhan, Swadesh K Das, et al.
Oncoimmunology|May 4, 2016
Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognitionXiao-Xiang Rong, Fang Wei, Xiao-Lin Lin, et al.
Oncoimmunology|May 4, 2016
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacyZuqiang Liu, Roshni Ravindranathan, Jun Li, et al.
Oncoimmunology|May 4, 2016
Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patientsShaodong Hong, Nan Chen, Wenfeng Fang, et al.
Oncoimmunology|May 4, 2016
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapyLi-Sheng Chang, Wan-Lun Yan, Yu-Wen Chang, et al.
Pageof 380